AZD7798 for crohn disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Nov 2024: Trial registered, NCT06681324
  2. 11 Dec 2024: Trial started, NCT06681324

The trials

NCT06681324: Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy

State
Under way
Phase
Phase 2
People
24 taking part
Started
11 Dec 2024
Primary completion
10 Aug 2026
Arms
AZD7798
Results
None posted
  1. 8 Nov 2024: Trial registered
  2. 11 Dec 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.